Castle Creek Pharmaceuticals, LLC — Form D
Castle Creek Pharmaceuticals, LLC of BEDMINSTER, NJ, a company, filed a Form D exempt-offering notice with the SEC on 2016-10-14. The offering totals $48.0M, of which $48.0M was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2016-10-14
- Form: D
- Accession: 0001687481-16-000001
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $48.0M
- Amount sold: $48.0M
- Investors: 6
- Date of first sale: 2016-09-29
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-272558
Issuer
- Name: Castle Creek Pharmaceuticals, LLC
- CIK: 0001687481
- Entity type: Limited Liability Company
- Jurisdiction: DELAWARE
- Incorporated: 2015
- Address: 90 WASHINGTON VALLEY ROAD, BEDMINSTER, NJ, 07921
- Phone: 908-719-8943
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| N/A Octagon Capital Group, LLC | Promoter | Millburn, NJ |
| ANTONIO GRACIAS | Director | Hawthorne, CA |
| Jeffrey Aronin | Director | Exton, PA |
| Patrick Morris | Director | Chicago, IL |
| Timothy Cunniff | Director | Chicago, IL |
| Greg Licholai | Executive Officer | Melville, NY |
| Michael Derby | Director | Laval, A8 |
| Michael Derby | Executive Officer | Laval, A8 |
Other filings by this issuer (1)
More